Labcorp

Strengthens LabCorp’s position as a global life sciences company with leading diagnostics and drug development businesses Creates a market-leading contract research organization (CRO), with significant global scale and more than 20,000 employees Enhances customer solutions, including customized models for emerging biopharma clients, expanded functional service provider (FSP) solutions and leading oncology expertise Highly complementary customer […]

LabCorp’s Proprietary Assay Offers Faster, More Accurate Diagnosis to Help Patients Receive Most-Appropriate Therapy BURLINGTON, N.C.–(BUSINESS WIRE)–Jul. 19, 2017– LabCorp® (NYSE: LH) has begun offering its new, proprietary ADAMTS13 test to distinguish diseases characterized by life-threatening, acute thrombotic microangiopathy (TMA). TMA is a relatively rare but serious syndrome in which small blood vessels develop blood […]